About Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas
Clinical Trials at Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas
During the past decade, Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas"
#1 collaborator was "Gilead Sciences, Inc., GlaxoSmithKline plc, Seattle Genetics and Astellas" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas
According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas" are
"Bladder Cancer" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas" in a lesser frequency.
Clinical Trials Intervention Types at Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas
Most popular intervention types in "Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Cisplatin" (1 trials), "Enfortumab Vedotin" (1 trials), "Gemcitabine" (1 trials) and "Magrolimab (Hu5F9-G4)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas
The vast majority of trials in "Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas" are
2 trials for "All" genders.
Clinical Trials Status at Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas
Currently, there are NaN active trials in "Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Complejo Hospitalario Universitario de Santiago (CHUS) ; Intermedios y Urgencias Pediatricas, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".